LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

AspenBio Launches Lateral Flow Division

By Labmedica staff writers
Posted on 18 Mar 2004
The launch of a Lateral Flow Division for the development, manufacturing, and distribution of immunochromatographic rapid tests has been announced by AspenBio, Inc. (Castle Rock, CO, USA).

Immunochromatographic tests are used to determine the presence or absence of minute quantities of target analyte in various types of samples within a few minutes and are particularly useful as clinical diagnostic tools. One example is the home pregnancy test. The tests can save clinicians up to 12 hours of laboratory time by replacing immunoblotting in some cases. AspenBio has developed tests for insulin, luteinizing hormone, growth hormone, alpha fetoprotein (AFP), mouse IgG, and thyroid stimulating hormone.

"Adding this division to AspenBio's capabilities is in response to requests from universities, research facilities, and veterinarians,” said Dr. Mark Colgin, chief scientist. "These initial devices, in addition to others currently being developed, will assist technicians, scientists, and doctors with reduced analytical costs and shortened turnaround times.”




Related Links:
AspenBio

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE

Latest Industry News

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
18 Mar 2004  |   Industry

Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
18 Mar 2004  |   Industry

New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
18 Mar 2004  |   Industry